CD4 and immunodeficiency disease: Third, we found that around 20% of the ALHIV did not have documented investigation/test results for CD4 cell count, hepatitis B, hepatitis C and haemoglobin at enrolment indicating missed opportunities for identifying cases with severe immunodeficiency and/or co-morbidities early.